Katherine E Kelley

Summary

Affiliation: Boston University
Country: USA

Publications

  1. pmc Identification of phthalates in medications and dietary supplement formulations in the United States and Canada
    Katherine E Kelley
    Slone Epidemiology Center at Boston University, Boston, Massachusetts 02215, USA
    Environ Health Perspect 120:379-84. 2012
  2. pmc Medications as a potential source of exposure to phthalates among women of childbearing age
    Sonia Hernandez-Diaz
    Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
    Reprod Toxicol 37:1-5. 2013
  3. pmc Medications as a potential source of exposure to phthalates in the U.S. population
    Sonia Hernandez-Diaz
    Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    Environ Health Perspect 117:185-9. 2009
  4. pmc Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008
    Allen A Mitchell
    Slone Epidemiology Center at Boston University, Boston, MA, USA
    Am J Obstet Gynecol 205:51.e1-8. 2011
  5. pmc Medications as a source of paraben exposure
    Laura E Dodge
    Department of Epidemiology, Harvard T H Chan School of Public Health, Boston, MA, USA
    Reprod Toxicol 52:93-100. 2015

Collaborators

Detail Information

Publications5

  1. pmc Identification of phthalates in medications and dietary supplement formulations in the United States and Canada
    Katherine E Kelley
    Slone Epidemiology Center at Boston University, Boston, Massachusetts 02215, USA
    Environ Health Perspect 120:379-84. 2012
    ..Limited evidence suggests that particularly high exposure levels may result from orally ingested medicinal products containing phthalates as excipients (inactive ingredients)...
  2. pmc Medications as a potential source of exposure to phthalates among women of childbearing age
    Sonia Hernandez-Diaz
    Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
    Reprod Toxicol 37:1-5. 2013
    ..To evaluate the association between the use of medications potentially containing phthalates and urinary concentrations of specific phthalate metabolites around conception...
  3. pmc Medications as a potential source of exposure to phthalates in the U.S. population
    Sonia Hernandez-Diaz
    Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    Environ Health Perspect 117:185-9. 2009
    ..Underappreciated sources of exposure include phthalates in the polymers coating some oral medications...
  4. pmc Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008
    Allen A Mitchell
    Slone Epidemiology Center at Boston University, Boston, MA, USA
    Am J Obstet Gynecol 205:51.e1-8. 2011
    ..The objective of the study was to provide information on overall medication use throughout pregnancy, with particular focus on the first trimester and specific prescription medications...
  5. pmc Medications as a source of paraben exposure
    Laura E Dodge
    Department of Epidemiology, Harvard T H Chan School of Public Health, Boston, MA, USA
    Reprod Toxicol 52:93-100. 2015
    ..Parabens are used as antimicrobial excipients in some pharmaceuticals. Parabens may adversely affect reproduction...